Hills Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Hills Bank & Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.13M	Sell	18,563 -5,496	-23%	-$320K	0.05%	152
2025 Q4	$1.3M	Sell	24,059 -10,134	-30%	-$488K	0.08%	138
2025 Q3	$1.54M	Buy	34,193 +50	+0.1%	+$2.33K	0.09%	120
2025 Q2	$1.58M	Sell	34,143 -1,751	-5%	-$86K	0.1%	117
2025 Q1	$2.19M	Buy	35,894 +10	+0%	+$583	0.15%	88
2024 Q4	$2.03M	Sell	35,884 -304	-0.8%	-$17K	0.15%	91
2024 Q3	$1.87M	Sell	36,188 -1,278	-3%	-$60K	0.14%	101
2024 Q2	$1.56M	Sell	37,466 -264	-0.7%	-$11.8K	0.13%	107
2024 Q1	$2.05M	Sell	37,730 -2,500	-6%	-$127K	0.17%	85
2023 Q4	$2.06M	Sell	40,230 -490	-1%	-$25.7K	0.2%	80
2023 Q3	$2.36M	Sell	40,720 -389	-0.9%	-$23.8K	0.27%	66
2023 Q2	$2.63M	Sell	41,109 -50	-0.1%	-$3.35K	0.34%	57
2023 Q1	$2.85M	Buy	41,159 +262	+0.6%	+$18.5K	0.39%	50
2022 Q4	$2.94M	Sell	40,897 -1,368	-3%	-$103K	0.43%	48
2022 Q3	$3M	Buy	42,265 +1,072	+3%	+$77.8K	0.44%	43
2022 Q2	$3.17M	Sell	41,193 -1,298	-3%	-$98.9K	0.52%	42
2022 Q1	$3.1M	Buy	42,491 +2,269	+6%	+$152K	0.44%	45
2021 Q4	$2.51M	Buy	40,222 +1,010	+3%	+$59.2K	0.34%	59
2021 Q3	$2.32M	Buy	39,212 +659	+2%	+$43.4K	0.35%	61
2021 Q2	$2.58M	Sell	38,553 -905	-2%	-$59K	0.39%	56
2021 Q1	$2.49M	Sell	39,458 -85	-0.2%	-$5.29K	0.4%	55
2020 Q4	$2.45M	Sell	39,543 -483	-1%	-$29.7K	0.43%	52
2020 Q3	$2.41M	Sell	40,026 -1,251	-3%	-$75.3K	0.47%	49
2020 Q2	$2.43M	Sell	41,277 -222	-0.5%	-$13.3K	0.51%	46
2020 Q1	$2.31M	Buy	41,499 +424	+1%	+$25.9K	0.68%	34
2019 Q4	$2.64M	Buy	41,075 +15,798	+62%	+$905K	0.62%	37
2019 Q3	$1.28M	Buy	25,277 +1,011	+4%	+$47.5K	0.32%	65
2019 Q2	$1.1M	Sell	24,266 -737	-3%	-$34.3K	0.28%	72
2019 Q1	$1.19M	Buy	25,003 +1,074	+4%	+$53.5K	0.32%	70
2018 Q4	$1.24M	Buy	23,929 +983	+4%	+$52.8K	0.39%	60
2018 Q3	$1.43M	Buy	22,946 +409	+2%	+$24.3K	0.38%	61
2018 Q2	$1.25M	Buy	22,537 +3,235	+17%	+$175K	0.36%	64
2018 Q1	$1.22M	Buy	19,302 +2,906	+18%	+$187K	0.37%	61
2017 Q4	$1M	Buy	16,396 +1,646	+11%	+$103K	0.29%	70
2017 Q3	$940K	Buy	14,750 +1,750	+13%	+$102K	0.3%	71
2017 Q2	$724K	Buy	13,000 +7,081	+120%	+$385K	0.23%	82
2017 Q1	$322K	Buy	5,919 +1,155	+24%	+$63.4K	0.11%	104
2016 Q4	$278K	Hold	4,764	–	–	0.1%	111
2016 Q3	$257K	Buy	4,764 +234	+5%	+$15K	0.09%	115
2016 Q2	$334K	Buy	4,530 +280	+7%	+$19.8K	0.12%	99
2016 Q1	$271K	Sell	4,250 -120	-3%	-$7.57K	0.1%	108
2015 Q4	$301K	Hold	4,370	–	–	0.11%	92
2015 Q3	$259K	Sell	4,370 -100	-2%	-$6.34K	0.1%	81
2015 Q2	$297K	Buy	4,470 +220	+5%	+$14.5K	0.11%	71
2015 Q1	$274K	Hold	4,250	–	–	0.1%	74
2014 Q4	$251K	Hold	4,250	–	–	0.1%	76
2014 Q3	$218K	Hold	4,250	–	–	0.09%	80
2014 Q2	$206K	Hold	4,250	–	–	0.09%	78
2014 Q1	$221K	Hold	4,250	–	–	0.09%	77
2013 Q4	$226K	Buy	+4,250	New	+$216K	0.1%	79

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hills Bank & Trust's BMY Position: Q1 2026 in Review

Hills Bank & Trust reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q1 2026, selling an estimated $320K and leaving 18,563 shares worth $1.13M. The position accounts for 0.05% of the portfolio, ranked #152.

Hills Bank & Trust first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $3.17M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Hills Bank & Trust held 18,563 shares of Bristol-Myers Squibb worth $1.13M as of Q1 2026.
Hills Bank & Trust sold 5,496 Bristol-Myers Squibb shares in Q1 2026, an estimated $320K.
Bristol-Myers Squibb made up 0.05% of Hills Bank & Trust's portfolio in Q1 2026, its #152 holding.
Hills Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
Hills Bank & Trust's Bristol-Myers Squibb position peaked at $3.17M in Q2 2022.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.